Real-world Safety of Vedolizumab and Anti-TNF Therapies in Biologic-Naïve Ulcerative Colitis and Crohn's Disease Patients: Results from the EVOLVE study

Andres Yarur  1     Gerassimos J. Mantzaris  2     Uri Kopylov  3     Marielle Bassel  4     Neil Brett  4     Trevor Lissoos  5     claudia lopez  5     Athanasios Natsios  6     Christina Kifnidi  7     Sumit Saha     Dirk Demuth     Haridarshan Patel     Brian Bressler    
1 Medical College of Wisconsin,Milwaukee,United States
2 Evangelismos Hospital,Athens,Greece
3 Chaim Sheba Medical Center,Ramat Gan,Israel
4 Evidera,Montreal,Canada
5 Takeda Pharmaceuticals USA Inc,Deerfield,United States
6 Takeda Hellas S.A.,Athens,Greece
7 T

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing